Primary Authors: D. Andrew Loblaw; Katherine S. Virgo; Robert Nam; Mark R. Somerfield; Edgar Ben-Josef; David S. Mendelson; Richard Middleton; Stewart A. Sharp; Thomas J. Smith; James Talcott; Maryellen Taplin; Nicholas J. Vogelzang; James L. Wade III; Charles L. Bennett; Howard I. Scher
ASCO Metastatic Prostrate Cancer Expert Panel: Howard I. Scher, MD, Cochair Memorial Sloan-Kettering Cancer Center; Charles L. Bennett, MD, PhD, Cochair VA Chicago Health Care System-Lakeside and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Edgar Ben-Josef, MD, Wayne State University; D. Andrew Loblaw, MD, MSc, Sunnybrook Health Sciences Centre; David S. Mendelson, MD, Premiere Oncology of Arizona; Richard Middleton, MD, University of Utah Medical School; Robert Nam, MD, MSc, Sunnybrook Health Sciences Centre; Thomas J. Smith, MD, Massey Cancer Center, Medical College of Virginia; Stewart A. Sharp, MD, Danville Hematology & Oncology, Inc; James Talcott, MD,MPH, Massachusetts General Hospital; Maryellen Taplin, MD, Dana-Farber Cancer Institute; Katherine S. Virgo, PhD, Saint Louis University & Department of Veterans' Affairs Medical Center; Nicholas J. Vogelzang, MD, University of Chicago Cancer Research Center; James L. Wade III, MD, Cancer Care Specialists of Central Illinois